Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports

Koh, Ming-Yi; Toh, Keith Zhi-Xian; Ho, Jamie Sin-Ying; Yeo, Leonard Leong‐Litt; Ho, Andrew Fu Wah; Sia, Ching‐Hui; Tan, Benjamin Yong‐Qiang

doi:10.1007/s11239-022-02670-0

Cited by 7 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A systematic review of 10 case reports showed successful reperfusion in 2 of 4 patients undergoing thrombectomy, and improvement in 5 of 9 patients with reported functional outcomes. 111…”

Section: Role Of Endovascular Managementmentioning

confidence: 99%

Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association

Gonzalez,

Amin-Hanjani,

Bang

et al. 2023

Stroke

View full text Add to dashboard Cite

Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. A writing group of experts was selected to conduct a literature search, summarize the current knowledge on the topic, and provide a road map for future investigation. The document presents an update in the definitions of moyamoya disease and syndrome, modern methods for diagnosis, and updated information on pathophysiology, epidemiology, and both medical and surgical treatment. Despite recent advancements, there are still many unresolved questions about moyamoya disease and syndrome, including lack of unified diagnostic criteria, reliable biomarkers, better understanding of the underlying pathophysiology, and stronger evidence for treatment guidelines. To advance progress in this area, it is crucial to acknowledge the limitations and weaknesses of current studies and explore new approaches, which are outlined in this scientific statement for future research strategies.

show abstract

“…A systematic review of 10 case reports showed successful reperfusion in 2 of 4 patients undergoing thrombectomy, and improvement in 5 of 9 patients with reported functional outcomes. 111…”

Section: Role Of Endovascular Managementmentioning

confidence: 99%

Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association

Gonzalez,

Amin-Hanjani,

Bang

et al. 2023

Stroke

View full text Add to dashboard Cite

show abstract

“…Revascularization surgery with indirect bypass may also be an effective method of indirectly treating cerebral aneurysms in MMD [ 50 ]. When patients present with acute IS, intravenous chemical thrombolysis and endovascular thrombectomy may be considered while carefully weighing the risk of hemorrhagic complications [ 51 – 53 ].…”

Section: Moyamoya Diseasementioning

confidence: 99%

Advances in Management of the Stroke Etiology One-Percenters

Osteraas

Dafer

2023

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

Purpose of Review Uncommon causes of stroke merit specific attention; when clinicians have less common etiologies of stoke in mind, the diagnosis may come more easily. This is key, as optimal management will in many cases differs significantly from “standard” care. Recent Findings Randomized controlled trials (RCT) on the best medical therapy in the treatment of cervical artery dissection (CeAD) have demonstrated low rates of ischemia with both antiplatelet and vitamin K antagonism. RCT evidence supports the use of anticoagulation with vitamin K antagonism in “high-risk” patients with antiphospholipid antibody syndrome (APLAS), and there is new evidence supporting the utilization of direct oral anticoagulation in malignancy-associated thrombosis. Migraine with aura has been more conclusively linked not only with increased risk of ischemic and hemorrhagic stroke, but also with cardiovascular mortality. Recent literature has surprisingly not provided support the utilization of l -arginine in the treatment of patients with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS); however, there is evidence at this time that support use of enzyme replacement in patients with Fabry disease. Additional triggers for reversible cerebral vasoconstriction syndrome (RCVS) have been identified, such as capsaicin. Imaging of cerebral blood vessel walls utilizing contrast-enhanced MRA is an emerging modality that may ultimately prove to be very useful in the evaluation of patients with uncommon causes of stroke. A plethora of associations between cerebrovascular disease and COVID-19 have been described. Where pertinent, authors provide additional tips and guidance. Summary Less commonly encountered conditions with updates in diagnosis, and management along with clinical tips are reviewed.

show abstract

GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease

Li,

Cao,

et al. 2023

Neurosci. Bull.

View full text Add to dashboard Cite

Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports

Cited by 7 publications

References 30 publications

Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association

Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association

Advances in Management of the Stroke Etiology One-Percenters

GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease

Contact Info

Product

Resources

About